Company Profiles

driven by the PitchBook Platform

NxThera

Description

Developer of a medical based thermal therapy device designed to treat prostate cancer and other endourologic conditions. The company's convective radio-frequency (RF) water vapor thermal therapy technology converts a few drops of sterile water to stored thermal energy in the form of vapor, which is delivered to prostate tissue to treat benign prostatic hyperplasia (BPH), targeting patients suffering from urologic conditions, prostate cancer, kidney cancer and can be used in an office-based, outpatient or hospital setting and providing improvements in urine flow.

2008

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$12.2M

Latest Deal Amount

$106M

Total Amount Raised

Description

Developer of a medical based thermal therapy device designed to treat prostate cancer and other endourologic conditions. The company's convective radio-frequency (RF) water vapor thermal therapy technology converts a few drops of sterile water to stored thermal energy in the form of vapor, which is delivered to prostate tissue to treat benign prostatic hyperplasia (BPH), targeting patients suffering from urologic conditions, prostate cancer, kidney cancer and can be used in an office-based, outpatient or hospital setting and providing improvements in urine flow.

Website:

www.nxthera.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

7351 Kirkwood Lane North Suite 138 Maple Grove, MN 55369United States +1 (763) 515-0404
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore NxThera's full profile, request a free trial.

NxThera Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

NxThera Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

NxThera Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aberdare VenturesVenture CapitalMinority000 0000000 0000
Alafi CapitalVenture CapitalMinority000 0000000 0000
Ally Bridge GroupVenture CapitalMinority000 0000000 0000
American Medical SystemsCorporationMinority000 0000000 0000
Arboretum VenturesVenture CapitalMinority000 0000000 0000
Aberdare Ventures Venture Capital
Alafi Capital Venture Capital
Ally Bridge Group Venture Capital
American Medical Systems Corporation
Arboretum Ventures Venture Capital

NxThera Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Robert Paulson JDPresident, Chief Executive Officer & Director
Carmen BringgoldChief Financial Officer & Senior Vice President, Commercialization
Maximillian FioreChief Development and Operations Officer
Michael HoeyCo-Founder, Chief Technology Officer & Board Member
Michael KujakChief Marketing Officer
Robert Paulson JD President, Chief Executive Officer & Director
Carmen Bringgold Chief Financial Officer & Senior Vice President, Commercialization
Maximillian Fiore Chief Development and Operations Officer
Michael Hoey Co-Founder, Chief Technology Officer & Board Member
Michael Kujak Chief Marketing Officer

NxThera Board Members (7)

NameRepresentingRoleSinceContact
Info
Andre de BruinSelfChairman000 0000
Jan GarfinkleArboretum VenturesFounder & Managing Director000 0000
Masashi KiyomineMitsui Global InvestmentInvestment Director000 0000
Michael HoeyNxTheraCo-Founder, Chief Technology Officer & Board Member000 0000
Robert Paulson JDNxTheraPresident, Chief Executive Officer & Director000 0000
Andre de Bruin Chairman Self
Jan Garfinkle Founder & Managing Director Arboretum Ventures
Masashi Kiyomine Investment Director Mitsui Global Investment
Michael Hoey Co-Founder, Chief Technology Officer & Board Member NxThera
Robert Paulson JD President, Chief Executive Officer & Director NxThera
Request full access to PitchBook